Naseptin Nasal Cream

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor of pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

1. What Naseptin is and what it is used for
2. What you need to know before you use Naseptin
3. How to use Naseptin
4. Possible side effects
5. How to store Naseptin
6. Contents of the pack and other information

• if you are allergic (hypersensitive) to chlorhexidine dihydrochloride, neomycin sulfate or any of the other ingredients of this medicine (listed in Section 6).

Talk to your doctor or pharmacist before using Naseptin

If you have hearing problems, it is important that you speak to your doctor before using Naseptin. Naseptin could make your hearing worse.

Also, before you use Naseptin, tell your doctor if:

• you are elderly
• the patient is a child.

If any of the above applies to you, or if you are not sure, speak to your doctor or pharmacist before you use Naseptin.

If Naseptin is mixed with certain soaps, it may not work properly.

If this happens, do not use bleach to remove it, as brown stains may develop.

Please tell your doctor or pharmacist if you are taking or have recently taken/used any other medicines, including medicines obtained without a prescription.

Naseptin is unlikely to have any effect on your unborn baby or on breast-feeding. Ask your doctor or pharmacist for advice before taking any medicine.

This product contains cetostearyl alcohol which may cause local skin reactions, for example contact dermatitis.

Use Naseptin twice a day to prevent infection.

Use Naseptin 4 times a day to treat infection. Treatment is usually for 10 days.

The amount you should use is the same for children, adults and the elderly.

Naseptin is only to be used inside your nose. Do not use it in your eyes or ears.

If you accidentally use too much cream, or someone else uses or swallows any of the cream, you should tell your doctor at once or contact your nearest accident and emergency department. Show any left-over cream or the empty container to the doctor.

If you forget to apply a dose, apply it as soon as possible, unless it is almost time to apply the next dose. Then go on as before. Do not apply a double dose.

• Signs of a severe allergic reaction such as:
  • swelling of the face, tongue or throat
  • difficulty breathing
  • dizziness
  • severe irritation, reddening or blistering of your skin.

Other possible side effects include:

• irritation of the skin
• hearing problems
• kidney problems (pain when you pass water, blood in your urine)
• if you use Naseptin for a long time, it may cause allergic skin reactions (redness or itching)
• temporary loss of your sense of smell or taste
• change of skin colour at the application site.

If they are severe or last for more than a few days, tell your doctor.

If you get any side effects, talk to your doctor or pharmacist.

This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

The active ingredients in this medicine are chlorhexidine dihydrochloride 0.1% w/w and neomycin sulfate 0.5% w/w.

The other ingredients are medium-chain triglycerides, cetostearyl alcohol/ethylene oxide condensate, cetostearyl alcohol and water.

Naseptin is a smooth, white cream.

Naseptin comes in aluminium tubes of 15g (grams).

The product licence holder is:

Naseptin is manufactured by:

The information in this leaflet applies only to Naseptin. If you have any questions or you are not sure about anything, ask your doctor or a pharmacist.

This leaflet was last revised in: June 2022.